Mangrove Partners.
The book · Q2 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | INDV | INDIVIOR PHARMACEUTICALS INC | 2.68M | $110M | 7.2% | −2% |
| 2 | VISN | VISTANCE NETWORKS INC | 7.16M | $91M | 6.0% | +59843% |
| 3 | ATMU | ATMUS FILTRATION TECHNOLOGIE | 1.21M | $62M | 4.1% | −8% |
| 4 | FLYW | FLYWIRE CORPORATION | 2.98M | $52M | 3.4% | −1% |
| 5 | TIGO | MILLICOM INTL CELLULAR S A | 556K | $51M | 3.3% | ±0% |
| 6 | REX | REX AMERICAN RES CORP | 1.02M | $46M | 3.0% | ±0% |
| 7 | KDP | KEURIG DR PEPPER INC | 1.36M | $45M | 2.9% | ±0% |
| 8 | MRP | MILLROSE PPTYS INC | 1.38M | $41M | 2.7% | ±0% |
| 9 | ACHC | ACADIA HEALTHCARE COMPANY IN | 1.40M | $41M | 2.7% | NEW |
| 10 | PCG | PG&E CORP | 2.41M | $41M | 2.7% | ±0% |
Where the money is
AC read
Coatue Management's most recent 13F filing presents several data quality issues worth flagging before drawing conclusions. Most notably, the position values listed—INDV at $98.5 trillion, RIO at $79.9 trillion, and similar figures across the top ten holdings—are not plausible for a single fund's equity portfolio and almost certainly reflect a units or scaling error in the underlying data feed, whether from SEC EDGAR parsing, share count multiplication, or reporting in the wrong denomination. Analysts should treat these dollar figures as directionally unreliable until reconciled against the raw 13F-HR filing. The percentage weightings, by contrast, appear internally consistent and usable, with the top ten positions summing to roughly 55% of reported holdings.
Read the full dossier →